United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - nisoldipine extended-release tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. nisoldipine extended-release tablets are contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

united research laboratories, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - nisoldipine is indicated for the treatment of hypertension. it maybe used alone or in combination with other antihypertensive agents. nisoldipine is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

prasco laboratories - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - nisoldipine is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. nisoldipine is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 40 mg - nisoldipine extended-release tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. nisoldipine extended-release tablets are contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine extended-release tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents. nisoldipine extended-release tablets are contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

shionogi inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

covis pharma us, inc - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 8.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - nisoldipine (unii: 4i8hab65sz) (nisoldipine - unii:4i8hab65sz) - nisoldipine 25.5 mg - sular is indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive agents. sular is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nisoldipine - modified-release tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - nisoldipine - modified-release tablet - 20mg